Abstract
A better understanding of the nonrandom localization patterns of gliomas across the brain could lend clues to the origins of these types of tumors. Following hypotheses derived from prior research into neuropsychiatric disease and cancer, gliomas may be expected to localize to brain regions characterized by hubness, stem-like cells, and transcription of genetic drivers of gliomagenesis. We combined neuroimaging data from 335 adult patients with high- and low-grade glioma to form a replicable tumor frequency map. Using this map, we demonstrated that glioma frequency is elevated in association cortex and correlated with multiple graph-theoretical metrics of high functional connectedness. Brain regions populated with stem-like cells also exhibited a high glioma frequency. Furthermore, gliomas were localized to brain regions enriched with the expression of genes associated with chromatin organization and synaptic signaling. Finally, a regression model incorporating connectomic, cellular, and genetic factors explained 58% of the variance in glioma frequency. Our findings illustrate how factors of diverse scale, from genetic to connectomic, can independently influence the anatomic localization of oncogenesis.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
A.S.M. was funded by a Gates Cambridge Scholarship. R.R.G. was funded by a Guarantors of Brain fellowship. Data were stored and processed on the High Performance Hub for Clinical Informatics (HPHI) platform, funded by a Medical Research Council (MRC) infrastructure award (MR/M009041/1).
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
This work made use of publicly-accessible datasets from the Brain Tumor Segmentation Challenge, UK BioBank, and Allen Institute for Brain Science
http://braintumorsegmentation.org/
